269 related articles for article (PubMed ID: 18248470)
1. Perioperative management of medications for psoriasis and psoriatic arthritis: a review for the dermasurgeon.
Hernandez C; Emer J; Robinson JK
Dermatol Surg; 2008 Apr; 34(4):446-59. PubMed ID: 18248470
[TBL] [Abstract][Full Text] [Related]
2. Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.
Busti AJ; Hooper JS; Amaya CJ; Kazi S
Pharmacotherapy; 2005 Nov; 25(11):1566-91. PubMed ID: 16232020
[TBL] [Abstract][Full Text] [Related]
3. Current perspectives in the recognition and management of psoriatic arthritis: implications for integrated patient care.
Ruderman EM
Am J Manag Care; 2002 Apr; 8(6 Suppl):S171-80. PubMed ID: 11990862
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of biologics with traditional agents in psoriasis.
Guenther LC
Skin Therapy Lett; 2011 Jun; 16(6):1-3. PubMed ID: 21833461
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis and psoriatic arthritis: separate or one and the same?
Ciocon DH; Kimball AB
Br J Dermatol; 2007 Nov; 157(5):850-60. PubMed ID: 17725671
[TBL] [Abstract][Full Text] [Related]
6. From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis.
Choi YM; Debbaneh M; Weinberg JM; Yamauchi PS; Van Voorhees AS; Armstrong AW; Siegel M; Wu JJ
J Am Acad Dermatol; 2016 Oct; 75(4):798-805.e7. PubMed ID: 27461230
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
8. The role of biological agents in the treatment of nail psoriasis.
Zaiac M
Am J Clin Dermatol; 2010; 11 Suppl 1():27-30. PubMed ID: 20586503
[TBL] [Abstract][Full Text] [Related]
9. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms.
Myers WA; Gottlieb AB; Mease P
Clin Dermatol; 2006; 24(5):438-47. PubMed ID: 16966023
[TBL] [Abstract][Full Text] [Related]
11. Treatment of refractory psoriatic arthritis.
Pioro MH; Cash JM
Rheum Dis Clin North Am; 1995 Feb; 21(1):129-49. PubMed ID: 7732164
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic immunomodulation and cutaneous malignancy in rheumatoid arthritis, psoriasis, and psoriatic arthritis.
Krathen MS; Gottlieb AB; Mease PJ
J Rheumatol; 2010 Nov; 37(11):2205-15. PubMed ID: 20810498
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
Yentzer BA; Yelverton CB; Simpson GL; Simpson JF; Hwang W; Balkrishnan R; Feldman SR
Dermatol Online J; 2009 Apr; 15(4):1. PubMed ID: 19450394
[TBL] [Abstract][Full Text] [Related]
14. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
15. Psoriatic disease--from skin to bone.
Ritchlin C
Nat Clin Pract Rheumatol; 2007 Dec; 3(12):698-706. PubMed ID: 18037929
[TBL] [Abstract][Full Text] [Related]
16. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases.
Lam J; Polifka JE; Dohil MA
J Am Acad Dermatol; 2008 Aug; 59(2):295-315. PubMed ID: 18410980
[TBL] [Abstract][Full Text] [Related]
17. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
Channual J; Wu JJ; Dann FJ
Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
[TBL] [Abstract][Full Text] [Related]
18. Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding.
Kurizky PS; Ferreira Cde C; Nogueira LS; Mota LM
An Bras Dermatol; 2015; 90(3):367-75. PubMed ID: 26131868
[TBL] [Abstract][Full Text] [Related]
19. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognosis in patients with psoriasis.
Gulliver W
Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
